These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19885904

  • 21. Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.
    Witthöft T, Ludwig D.
    Int J Colorectal Dis; 2005 Jan; 20(1):18-23. PubMed ID: 15459773
    [Abstract] [Full Text] [Related]

  • 22. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
    Wagner TE, Huseby ES, Huseby JS.
    Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
    [No Abstract] [Full Text] [Related]

  • 23. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS, Saad A, Bortman JS, Amin M.
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The relationship between infliximab treatment and lymphoma in Crohn's disease.
    Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F.
    Gastroenterology; 1999 Dec; 117(6):1433-7. PubMed ID: 10579985
    [Abstract] [Full Text] [Related]

  • 26. Long-term durability of infliximab treatment in Crohn's disease and efficacy of dose "escalation" in patients losing response.
    Chaparro M, Panes J, García V, Mañosa M, Esteve M, Merino O, Andreu M, Gutierrez A, Gomollón F, Cabriada JL, Montoro MA, Mendoza JL, Nos P, Gisbert JP.
    J Clin Gastroenterol; 2011 Feb; 45(2):113-8. PubMed ID: 21242747
    [Abstract] [Full Text] [Related]

  • 27. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV.
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease.
    Burger DC, Florin TH.
    Inflamm Bowel Dis; 2009 Dec; 15(12):1772. PubMed ID: 19170193
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H, Knoflach P, Petritsch W, Vogelsang H, Reinisch W, Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH.
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract] [Full Text] [Related]

  • 32. Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease.
    Bell S, Kamm MA.
    Lancet; 2000 Mar 11; 355(9207):858-60. PubMed ID: 10752696
    [No Abstract] [Full Text] [Related]

  • 33. Infliximab (Remicade): the magic bullet for Crohn's disease?
    D'Haens G.
    Dig Liver Dis; 2000 Nov 11; 32(8):653-6. PubMed ID: 11142571
    [No Abstract] [Full Text] [Related]

  • 34. Mortality associated with infliximab.
    Lankarani KB.
    J Clin Gastroenterol; 2001 Sep 11; 33(3):255-6. PubMed ID: 11500623
    [No Abstract] [Full Text] [Related]

  • 35. Immortal time bias in estimates of mortality among infliximab-treated patients with Crohn's disease.
    Lewis JD.
    Gut; 2010 Nov 11; 59(11):1586-7. PubMed ID: 20732919
    [No Abstract] [Full Text] [Related]

  • 36. [Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease].
    Osuna Molina R, Ferrer Ríos T, Gallego Gallegos R, Ramos Lora M, Ynfante Ferrús M, Figueruela López B.
    Rev Esp Enferm Dig; 2006 Jan 11; 98(1):60-1. PubMed ID: 16555939
    [No Abstract] [Full Text] [Related]

  • 37. Infliximab for severe peripheral ulcerative keratopathy revealing Crohn's disease.
    Angioi K, Kaminsky P, Peyrin-Biroulet L.
    Inflamm Bowel Dis; 2011 Mar 11; 17(3):866-7. PubMed ID: 20848541
    [No Abstract] [Full Text] [Related]

  • 38. Infliximab in Crohn's disease.
    Rodrigo Saéz L.
    Rev Esp Enferm Dig; 2004 Jun 11; 96(6):359-63; 364-8. PubMed ID: 15230665
    [No Abstract] [Full Text] [Related]

  • 39. Neurological symptoms suggestive of demyelination in Crohn's disease after infliximab therapy.
    Dubcenco E, Ottaway CA, Chen DL, Baker JP.
    Eur J Gastroenterol Hepatol; 2006 May 11; 18(5):565-6. PubMed ID: 16607158
    [Abstract] [Full Text] [Related]

  • 40. Severe anaphylactic reaction to infliximab in pediatric patients with Crohn's disease.
    Diamanti A, Castro M, Papadatou B, Ferretti F, Gambarara M.
    J Pediatr; 2002 May 11; 140(5):636-7; author reply 637. PubMed ID: 12032538
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.